The hRAD54 protein belongs to a superfamily of DNA helicases, and mutations
in genes with DNA helicase function have been found to be responsible for
cancer-prone syndromes (xeroderma pigmentosum, Bloom syndrome, Werner syndr
ome). hRAD54 thus could be a candidate modifier gene in tumors characterize
d by allelic imbalance at 1p32, the chromosome region in which this gene is
located. Using a panel of 38 1p and five 1q markers, we therefore performe
d deletion-mapping analysis on a series of 35 oligodendrogliomas, which wer
e also studied for mutations in the hRAD54 gene. Deletions of the short arm
of chromosome 1 were evidenced in 26 tumors, mostly involving 1p36-1p13; a
ll thus displayed loss of the 1p32 region. We used PCR/SSCP to examine all
18 exons of the hRAD54 gene for mutations in 25 tumors, but the mobility sh
ifts detected corresponded to previously identified polymorphic changes: T-
to-C transition at nucleotide 2865 (with no amino acid change) and at nucle
otide 3008, at the 3' untranslated region. We conclude that hRAD54 gene alt
erations are not required for malignant transformation of oligodendroglioma
s. (C) Elsevier Science, Inc., 1999. All Rights Reserved.